• Skip to main content
  • Skip to secondary menu
  • Skip to primary sidebar
  • Skip to secondary sidebar
  • Skip to footer

  • Opinion
  • Health IT
    • Behavioral Health
    • Care Coordination
    • EMR/EHR
    • Interoperability
    • Patient Engagement
    • Population Health Management
    • Revenue Cycle Management
    • Social Determinants of Health
  • Digital Health
    • AI
    • Blockchain
    • Precision Medicine
    • Telehealth
    • Wearables
  • Life Sciences
  • Investments
  • M&A
  • Value-based Care
    • Accountable Care (ACOs)
    • Medicare Advantage

DrChrono, Genomind Partner on EHR-Integrated Personalized Genetic Tests

by Jasmine Pennic 10/01/2018 Leave a Comment

  • LinkedIn
  • Twitter
  • Facebook
  • Email
  • Print

DrChrono, Genomind Partner on EHR-Integrated Personalized Genetic Tests

EHR provider DrChrono Inc. and Genomind, which offers a unique personalized medicine platform that brings innovation to healthcare around the world, today announce a partnership to meet the growing need from both patients and doctors for personalized genetic tests that integrate with electronic health records.

AS part of the partnership, physician practices using DrChrono’s platform can order test kits for Genomind’s Genecept Assay®, which helps guide mental health treatment and has been used by over 120,000 patients. The partnership also includes Genomind’s Mindful DNA Professional®, a genetic test used by clinicians that helps guide lifestyle, diet and/or nutritional supplement decisions to improve the overall health and wellbeing of patients.

The partnership means participating doctors can access Genecept Assay and Mindful DNA Professional patient test results and use Genomind’s real-time gene-drug-environmental interaction tool, Genomind Drug Interaction Guide (G-DIG)®.  G-DIG allows the clinician to utilize the Genecept Assay results and enter a current medication regiment when considering what medications to prescribe to a patient; it quickly checks for gene-drug and drug-drug interactions.

Clinicians and patients will benefit in important ways from the partnership.  When a physician orders test kits through the DrChrono electronic health record platform, it will capture patient demographics and applicable clinical information.  Doctors also will be able to see test results in the application, and final results are stored in the DrChrono information library for the patient, becoming part of the patient’s medical record.

 

“We are proud that DrChrono, after a thorough review, has chosen Genomind for this important initiative.  DrChrono is a leader in helping doctors focus on what matters most—the patient,” said Dr. David Krause, Chief Medical Officer at Genomind.  “We often hear from patients whose health and quality of life have been dramatically improved by Genomind’s genetic test products, whether in the form of medication optimization through information provided by the Genecept Assay or an improvement in wellness provided by Mindful DNA Professional results. We are excited to help even more patients get better, by partnering with DrChrono and the practices it supports.”

  • LinkedIn
  • Twitter
  • Facebook
  • Email
  • Print

Tagged With: drchrono, Genetic Tests

Tap Native

Get in-depth healthcare technology analysis and commentary delivered straight to your email weekly

Reader Interactions

Primary Sidebar

Subscribe to HIT Consultant

Latest insightful articles delivered straight to your inbox weekly.

Submit a Tip or Pitch

Featured Research Report

2026 Best in KLAS Awards: The Full List of Software & Services Winners

Most-Read

The "Platform" Squeeze: Epic Releases Native AI Charting, Putting Venture-Backed Scribes on Notice

The “Platform” Squeeze: Epic Releases Native AI Charting, Putting Venture-Backed Scribes on Notice

Analysis: Oracle Cerner’s Plans for a National EHR

Oracle May Cut 30k Jobs and Sell Cerner to Fund $156B OpenAI Deal

The $1.9B Exit: Why CommonSpirit is Insourcing Revenue Cycle and Tenet is Betting Big on Conifer AI

The $1.9B Exit: Why CommonSpirit is Insourcing Revenue Cycle and Tenet is Betting Big on Conifer AI

KLAS 2026 Rankings: Aledade and Guidehealth Named Top VBC Enablement Firms

KLAS 2026 Rankings: Aledade and Guidehealth Named Top VBC Enablement Firms

Beyond the Hype: New KLAS Data Validates the Financial and Clinical ROI of Ambient AI

Beyond the Hype: New KLAS Data Validates the Financial and Clinical ROI of Ambient AI

Anthropic Debuts ‘Claude for Healthcare’ and Opus 4.5 to Engineer the Future of Life Sciences

Anthropic Debuts ‘Claude for Healthcare’ and Opus 4.5 to Engineer the Future of Life Sciences

OpenAI Debuts ChatGPT Health: A ‘Digital Front Door’ That Connects Medical Records to Agentic AI

OpenAI Debuts ChatGPT Health: A ‘Digital Front Door’ That Connects Medical Records to Agentic AI

From Genes to Hackers: The Hidden Cybersecurity Risks in Life Sciences

From Genes to Hackers: The Hidden Cybersecurity Risks in Life Sciences

Utah Becomes First State to Approve AI System for Prescription Renewals

Utah Becomes First State to Approve AI System for Prescription Renewals

NYC Health + Hospitals to Acquire Maimonides in $2.2B Safety Net Overhaul

NYC Health + Hospitals to Acquire Maimonides in $2.2B Safety Net Overhaul

Secondary Sidebar

Footer

Company

  • About Us
  • 2026 Editorial Calendar
  • Advertise with Us
  • Reprints and Permissions
  • Op-Ed Submission Guidelines
  • Contact
  • Subscribe

Editorial Coverage

  • Opinion
  • Health IT
    • Care Coordination
    • EMR/EHR
    • Interoperability
    • Population Health Management
    • Revenue Cycle Management
  • Digital Health
    • Artificial Intelligence
    • Blockchain Tech
    • Precision Medicine
    • Telehealth
    • Wearables
  • Startups
  • Value-Based Care
    • Accountable Care
    • Medicare Advantage

Connect

Subscribe to HIT Consultant Media

Latest insightful articles delivered straight to your inbox weekly

Copyright © 2026. HIT Consultant Media. All Rights Reserved. Privacy Policy |